Atossa Genetics Price to Book Ratio 2012-2025 | ATOS
Historical price to book ratio values for Atossa Genetics (ATOS) over the last 10 years. The current price to book ratio for Atossa Genetics as of January 16, 2026 is 1.60.
| Atossa Genetics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-16 | 0.62 | 1.60 | |
| 2025-09-30 | 0.87 | $0.39 | 2.25 |
| 2025-06-30 | 0.83 | $0.45 | 1.86 |
| 2025-03-31 | 0.67 | $0.51 | 1.33 |
| 2024-12-31 | 0.94 | $0.55 | 1.71 |
| 2024-09-30 | 1.52 | $0.59 | 2.57 |
| 2024-06-30 | 1.19 | $0.64 | 1.85 |
| 2024-03-31 | 1.80 | $0.69 | 2.61 |
| 2023-12-31 | 0.88 | $0.73 | 1.20 |
| 2023-09-30 | 0.74 | $0.78 | 0.94 |
| 2023-06-30 | 1.26 | $0.83 | 1.52 |
| 2023-03-31 | 0.72 | $0.89 | 0.81 |
| 2022-12-31 | 0.53 | $0.93 | 0.57 |
| 2022-09-30 | 0.83 | $0.98 | 0.85 |
| 2022-06-30 | 1.09 | $1.03 | 1.06 |
| 2022-03-31 | 1.25 | $1.07 | 1.17 |
| 2021-12-31 | 1.60 | $1.09 | 1.47 |
| 2021-09-30 | 3.26 | $1.12 | 2.92 |
| 2021-06-30 | 6.32 | $1.14 | 5.52 |
| 2021-03-31 | 2.11 | $1.16 | 1.82 |
| 2020-12-31 | 0.95 | $0.57 | 1.66 |
| 2020-09-30 | 2.42 | $0.94 | 2.57 |
| 2020-06-30 | 3.80 | $0.90 | 4.22 |
| 2020-03-31 | 1.33 | $1.19 | 1.11 |
| 2019-12-31 | 1.57 | $1.44 | 1.09 |
| 2019-09-30 | 1.96 | $1.64 | 1.19 |
| 2019-06-30 | 2.55 | $1.92 | 1.33 |
| 2019-03-31 | 3.52 | $2.14 | 1.65 |
| 2018-12-31 | 1.02 | $1.51 | 0.68 |
| 2018-09-30 | 1.75 | $1.91 | 0.91 |
| 2018-06-30 | 2.20 | $2.78 | 0.79 |
| 2018-03-31 | 5.35 | $1.98 | 2.70 |
| 2017-12-31 | 3.16 | $2.62 | 1.21 |
| 2017-09-30 | 6.36 | $2.19 | 2.90 |
| 2017-06-30 | 6.00 | $3.35 | 1.79 |
| 2017-03-31 | 9.12 | $4.85 | 1.88 |
| 2016-12-31 | 16.92 | $9.82 | 1.72 |
| 2016-09-30 | 25.20 | $17.16 | 1.47 |
| 2016-06-30 | 50.40 | $10.96 | 4.60 |
| 2016-03-31 | 61.92 | $17.49 | 3.54 |
| 2015-12-31 | 57.60 | $20.63 | 2.79 |
| 2015-09-30 | 138.60 | $53.55 | 2.59 |
| 2015-06-30 | 203.40 | $81.33 | 2.50 |
| 2015-03-31 | 324.00 | $68.01 | 4.76 |
| 2014-12-31 | 257.40 | $69.59 | 3.70 |
| 2014-09-30 | 243.00 | $111.61 | 2.18 |
| 2014-06-30 | 302.40 | $134.42 | 2.25 |
| 2014-03-31 | 304.20 | $156.94 | 1.94 |
| 2013-12-31 | 417.60 | $102.73 | 4.07 |
| 2013-09-30 | 1011.60 | $119.06 | 8.50 |
| 2013-06-30 | 936.00 | $97.17 | 9.63 |
| 2013-03-31 | 1575.00 | $86.54 | 18.20 |
| 2012-12-31 | 702.00 | $72.10 | 9.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.079B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.458B | 27.62 |
| Intuitive Surgical (ISRG) | United States | $191.785B | 75.04 |
| IDEXX Laboratories (IDXX) | United States | $57.123B | 56.73 |
| Edwards Lifesciences (EW) | United States | $48.948B | 32.82 |
| IQVIA Holdings (IQV) | United States | $40.477B | 22.57 |
| Mettler-Toledo (MTD) | United States | $29.838B | 34.91 |
| DexCom (DXCM) | United States | $27.122B | 37.39 |
| STERIS (STE) | Ireland | $26.367B | 27.22 |
| Waters (WAT) | United States | $23.067B | 30.50 |
| Coloplast (CLPBY) | Denmark | $20.080B | 34.27 |
| Hologic (HOLX) | United States | $16.713B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.207B | 0.00 |
| Penumbra (PEN) | United States | $13.737B | 96.63 |
| Globus Medical (GMED) | United States | $12.510B | 26.26 |
| Masimo (MASI) | United States | $7.630B | 24.45 |
| Glaukos (GKOS) | United States | $6.906B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.194B | 19.68 |
| TransMedics (TMDX) | United States | $4.900B | 58.04 |
| Teleflex (TFX) | United States | $4.552B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.392B | 18.32 |
| Veracyte (VCYT) | United States | $3.286B | 37.45 |
| Integer Holdings (ITGR) | United States | $3.006B | 14.11 |
| Alphatec Holdings (ATEC) | United States | $2.635B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.510B | 23.48 |
| Artivion (AORT) | United States | $2.056B | 94.33 |
| Nihon Kohden (NHNKY) | Japan | $2.038B | 17.79 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| PROCEPT BioRobotics (PRCT) | United States | $1.698B | 0.00 |
| AxoGen (AXGN) | United States | $1.431B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.367B | 0.00 |
| IRadimed (IRMD) | United States | $1.298B | 61.82 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.967B | 5.24 |
| Pulse Biosciences (PLSE) | United States | $0.966B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.814B | 0.00 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.680B | 39.56 |
| Pacific Biosciences Of California (PACB) | United States | $0.667B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.43 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.556B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.490B | 13.52 |
| OrthoPediatrics (KIDS) | United States | $0.460B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.431B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.416B | 0.00 |
| RxSight (RXST) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| Sight Sciences (SGHT) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.211B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.206B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.185B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.168B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| CVRx (CVRX) | United States | $0.137B | 0.00 |
| Solana (HSDT) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.130B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.129B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.031B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Venus Concept (VERO) | Canada | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.55 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Alcon (ALC) | Switzerland | $0.000B | 26.33 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |